75 related articles for article (PubMed ID: 27174173)
1. Cyclin D1 Gene Silencing by siRNA in Ex Vivo Human Tissue Cultures.
Piazza O; Russo I; Bochicchio S; Barba AA; Lamberti G; Zeppa P; Crescenzo VD; Carrizzo A; Vecchione C; Ciacci C
Curr Drug Deliv; 2017; 14(2):246-252. PubMed ID: 27174173
[TBL] [Abstract][Full Text] [Related]
2. siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.
Russo I; Carrizzo A; Bochicchio S; Piazza O; Lamberti G; Barba AA; Vecchione C; Zeppa P; Iovino P; Bucci C; Santonicola A; Ciacci C
Transl Med UniSa; 2017 Jul; 17():25-33. PubMed ID: 30083520
[TBL] [Abstract][Full Text] [Related]
3. siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.
Russo I; Carrizzo A; Bochicchio S; Piazza O; Lamberti G; Barba AA; Vecchione C; Zeppa P; Iovino P; Bucci C; Santonicola A; Ciacci C
Transl Med UniSa; 2017 Jul; 17():22-30. PubMed ID: 30050877
[TBL] [Abstract][Full Text] [Related]
4. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
Yasui M; Yamamoto H; Ngan CY; Damdinsuren B; Sugita Y; Fukunaga H; Gu J; Maeda M; Takemasa I; Ikeda M; Fujio Y; Sekimoto M; Matsuura N; Weinstein IB; Monden M
Clin Cancer Res; 2006 Aug; 12(15):4720-9. PubMed ID: 16899623
[TBL] [Abstract][Full Text] [Related]
5. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target.
Peer D; Park EJ; Morishita Y; Carman CV; Shimaoka M
Science; 2008 Feb; 319(5863):627-30. PubMed ID: 18239128
[TBL] [Abstract][Full Text] [Related]
6. [In vitro gene silencing by siRNA of cyclin D1 on tongue squamous cell carcinoma cell line resistant to cisplatin].
Zhou XJ; Zhang ZY; Zhang P; Pan HY; Chen WT; Ye DX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov; 41(11):646-9. PubMed ID: 17331354
[TBL] [Abstract][Full Text] [Related]
7. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.
Kriegel C; Amiji MM
Clin Transl Gastroenterol; 2011 Mar; 2(3):e2. PubMed ID: 23237848
[TBL] [Abstract][Full Text] [Related]
8. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
Weinstein S; Toker IA; Emmanuel R; Ramishetti S; Hazan-Halevy I; Rosenblum D; Goldsmith M; Abraham A; Benjamini O; Bairey O; Raanani P; Nagler A; Lieberman J; Peer D
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E16-22. PubMed ID: 26699502
[TBL] [Abstract][Full Text] [Related]
9. Designing dual-targeting siRNA duplexes having two active strands that combine siRNA and microRNA-like targeting.
Sætrom P
Methods Mol Biol; 2013; 942():169-77. PubMed ID: 23027051
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
11. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
12. [Effect of silencing AEG-1 with small interfering RNA on the proliferation and cell cycle of gastric carcinoma SGC-7901 cells].
Zhang CF; Xia YH; Zheng QF; Li ZJ; Guo XH; Zhou HC; Zhang LL; Dong LP; Han Y; Liu ZE; Wang WJ; Luo YL
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):22-7. PubMed ID: 23648295
[TBL] [Abstract][Full Text] [Related]
13. RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice.
Gutbier B; Kube SM; Reppe K; Santel A; Lange C; Kaufmann J; Suttorp N; Witzenrath M
Pulm Pharmacol Ther; 2010 Aug; 23(4):334-44. PubMed ID: 20362688
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gene silencing in human vascular cells using small interfering RNAs.
Andersen ND; Monahan TS; Malek JY; Jain M; Daniel S; Caron LD; Pradhan L; Ferran C; Logerfo FW
J Am Coll Surg; 2007 Mar; 204(3):399-408. PubMed ID: 17324773
[TBL] [Abstract][Full Text] [Related]
15. [siRNA-cyclin D1 inhibit cell proliferation in breast cancer MCF-7 cell line].
Jiang L; Chen RS; Li JC
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Apr; 39(2):118-22. PubMed ID: 16944582
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
18. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
[TBL] [Abstract][Full Text] [Related]
19. In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer.
Bochicchio S; Dapas B; Russo I; Ciacci C; Piazza O; De Smedt S; Pottie E; Barba AA; Grassi G
Int J Pharm; 2017 Jun; 525(2):377-387. PubMed ID: 28189855
[TBL] [Abstract][Full Text] [Related]
20. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
